Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)

NCT07625332 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Spinal Cord Injury
Traumatic Spinal Cord Injury
Paraplegia and Tetraplegia
Metabolic Syndrome

Interventions

DRUG: Galantamine Hydrobromide Extended Release

Sponsor

Northwell Health

Collaborators

[object Object]
[object Object]